Mepenzolate is an anticholinergic drug used to reduce stomach acid production and to treat certain gastrointestinal disorders. It is also used to treat certain bladder and gastrointestinal conditions, such as irritable bowel syndrome and urinary retention. Mepenzolate works by blocking the action of a chemical in the body called acetylcholine, which helps control muscle contractions in the stomach and intestines. It is available in both oral and injectable forms.
Mepenzolate is a medication classified as an anticholinergic. Here's a breakdown of its key aspects:
Function:
- It acts as a postganglionic parasympathetic inhibitor. This means it blocks the action of the acetylcholine neurotransmitter at specific sites in the body.
Effects:
- By blocking acetylcholine, mepenzolate reduces stomach acid and pepsin secretion.
- It also suppresses muscle contractions in the colon.
Uses:
- In the past, it was used for peptic ulcers, but there are more effective medications available now.
Current Use:
- Limited use exists for some gastrointestinal conditions like irritable bowel syndrome.
Important Points:
- Mepenzolate is not typically the first-choice treatment for ulcers.
- It has been shown to have minimal impact on ulcer healing or preventing recurrence.
Availability:
- Sold under the brand name Cantil in tablet form.
Things to Consider:
- Mepenzolate can cause side effects, like dry mouth, constipation, blurred vision, and difficulty urinating.
- It's important to consult a doctor before taking it, especially if you have certain medical conditions or are taking other medications.
Anatomical Therapeutic Chemical Classification
A - Alimentary tract and metabolism
A03 Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB Synthetic anticholinergics, quaternary ammonium compounds
ATC Code
External Links
Mepenzolate